Insights into the United States Sleep-Wake Disorder Industry to 2025 - Extensive Profiles and Recent Developments of Market Players - ResearchAndMarkets.com

DUBLIN--()--The "US Sleep-Wake Disorder Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

The US sleep-wake disorder market is estimated to grow at a CAGR of 6.0% during the forecast period. The growth of the sleep-wake disorder market in the US is attributed to the presenvce of well-established healthcare infrastructure, rise in awareness among people, and an increase in the prevalence of sleep disorders. As per the World Bank, the aging population of US was around 52.3 million. The geriatric population is more prone to sleep-wake disorders. In addition, the presence of major market players, including ResMed Inc., Neurocrine Biosciences, Inc., and others further supports the growth of sleep-wake disorder market in the region during the forecast period.

The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.

Companies Mentioned

  • Aeroflow, Inc.
  • Arena Pharmaceuticals, Inc.
  • Acorda Therapeutics, Inc.
  • Merck & Co., Inc.
  • Natus Medical Inc.
  • Pfizer Inc.
  • ResMed Inc.
  • RespireRx Pharmaceuticals Inc.
  • Somnarus Inc.
  • Somnetics International Inc.
  • TotalCare eHealth

The Report Covers

  • Comprehensive research methodology of the US Sleep-Wake Disorder Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the US Sleep-Wake Disorder Market.
  • Insights about market determinants which are stimulating the US Sleep-Wake Disorder Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Key Topics Covered:

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. US Sleep-Wake Disorder Market by Type

5.1.1. Insomnia

5.1.2. Hypersomnia

5.1.3. Circadian Rhythm Disorders

5.1.4. Others

5.2. US Sleep-Wake Disorder Market by Treatment

5.2.1. Therapies

5.2.2. Drugs

5.2.3. Devices

6. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/6jookt

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900